HeartFlow will be attending RSNA 2024 in Chicago in just 1 week's time. Join us to discover how we're transforming cardiac care with our groundbreaking, non-invasive technology. Stop by Booth #8008 to learn more about our innovative solutions and how we're empowering clinicians to make more informed decisions and improve patient outcomes. Don't miss the chance to see the future of heart health technology in action. Fill out this form if you're interested in connecting with someone at HeartFlow: https://bit.ly/3OminOq. See you in Chicago! #RSNA2024 #HeartFlow
关于我们
HeartFlow is a medical technology company transforming the way cardiovascular disease is diagnosed and treated. With our HeartFlow Analysis, a non-invasive personalized cardiac test, physicians are able to make better care decisions for their patients with suspected coronary artery disease--the number one killer of men and women worldwide. HeartFlow is backed by decades of scientific research and development and leverages the latest advancements in technology to help set a new standard of care for diagnosing cardiovascular care worldwide. Cleared for use in the United States, Canada, Europe and Japan with offices in Mountain View, Austin, London and Japan, HeartFlow's footprint is growing rapidly. HeartFlow has received more than $215 million dollars in funding in a recent Series F financing round, is pre-IPO and leverages the latest technology including deep learning and computational fluid dynamics. We try to embody the best of both technology and healthcare companies and hire people who are passionate about living our mission to save lives, improve the patient experience and reduce the overall cost of care. For more information, visit www.heartflow.com.
- 网站
-
https://www.heartflow.com
HeartFlow, Inc的外部链接
- 所属行业
- 医疗设备制造业
- 规模
- 201-500 人
- 总部
- Mountain View，California
- 类型
- 私人持股
- 创立
- 2010
地点
HeartFlow, Inc员工
动态
-
?? Big News! Medicare coverage for HeartFlow Plaque Analysis is now officially live across the United States! This breakthrough means patients with stable or acute chest pain and <70% stenosis (CAD-RADS 1-3) now have access to the only FDA-cleared, AI-enabled plaque quantification tool with 95% agreement to IVUS. Get more information here: https://bit.ly/4eIWJP3. #HeartFlow #HealthcareInnovation #MedicareCoverage #PlaqueAnalysis #CardiacCare
-
-
We're thrilled to announce that #HeartFlow will be participating at the Gulf Intervention Society congress in Dubai! Join us on Friday, November 29, from 10:50-11:00am in the Main Hall at InterContinental Dubai Festival City for a talk by Prof. Nick Curzen. He will discuss the pivotal role of CCTA and AI in revolutionizing cardiovascular medicine and enhancing the integrated care pathway for chest pain patients, as part of the main session on Mastering Integrated Cardiac Imaging & Physiology. Don't miss this exciting opportunity to learn how these technologies are transforming cardiovascular care. Al Naghi Medical #GIS2024 #Cardiology #CCTA #AI #CardiacImaging
-
-
What an incredible experience at the American Heart Association Scientific Sessions 2024 in Chicago!?Thank you to everyone who visited our booth and joined us at our roundtable educational session which was led by Drs. Seth Shay Martin, Matthew Budoff and Malissa Wood. ? Together, we’re paving the way for innovation in cardiac care and improving patient outcomes. We will take the insights you shared with us back to our work at HeartFlow and continue our mission to transform precision heartcare. Until next time, Chicago! ???? #AHA2024 #HeartFlow #YesCCT
-
-
Please join us in congratulating Bellin Health as a recipient of HeartFlow's CT Quality Award. The team pictured here has been selected as a winner for multiple quarters: Q3 and Q4 2023 and Q2 2024. We're proud to work with such a dedicated site and look forward to our continued partnership of bringing the full picture of your patient's heart health with you all! #HeartFlow #FFRCT #CCTA #AI #heartcare #AI
-
-
Did you hear HeartFlow used a large international cohort to analyze more than 11,000 CCTAs to stratify total coronary atherosclerotic plaque volumes by age and sex? Physicians can utilize this data to help manage and optimize patient care https://bit.ly/4abw4tf. #Plaque #HeartFlowPlaqueAnalysis #HeartFlow
-
-
It's not too late to sign up for tomorrow's webinar at 12PM ET / 9AM PT! We'll be joined by industry experts to discuss the clinical utility of the HeartFlow Platform, the potential of HeartFlow's Plaque Analysis and recent updates to the reimbursement landscape surrounding these advanced technologies. Come join this insightful discussion with Cone Health Heart and Vascular Center's, Dr. Wesley O'Neal, Tim Fonte, HeartFlow Chief Technology Officer and Cara Santillo, HeartFlow Senior VP, Market Access and Reimbursement. Register now: https://bit.ly/4hORVdL. #HeartFlow #SCCT #Plaque
-
-
When Rod Norling began having difficulty exercising and experienced shortness of breath, he dismissed it as issues related to a rib injury. But when a pre-op ECG showed irregularities, he knew it was time to take his issues seriously. His cardiologist ordered a CT and #HeartFlowAnalysis. Learn more about Rod's experience with our technology and how he was able to get the necessary treatment: https://bit.ly/3sIt3Px.
-
-
??? Today's the day! Join us at the American Heart Association Scientific Sessions 2024 for an insightful roundtable with Drs. Matthew Budoff, Seth Martin and Malissa Wood hosted by HeartFlow! ?? When: 3:15-3:45 PM ?? Where: Cardio Talk Theater II (#2550) - Science & Technology Hall Dive into discussions on the latest advancements and clinical evidence in cardiac imaging and how we can enhance patient care together. Don't miss out! #AHA2024 #HeartFlow
-
-
#DYK that a CT-first approach optimizes efficiency in the cath lab? Hear from Columbia University's Dr. Sahil Parikh on how results from the PRECISE Trial can help optimize efficiency for both patients and the cath lab. #HeartFlow #FFRct #CAD #AI